Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals) - Global Forecast to 2025

止血/凝固アナライザーの世界市場予測(~2025):製品別、検査別、技術別、エンドユーザー別

◆タイトル:Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals) - Global Forecast to 2025
◆商品コード:AST 7689
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年6月22日
◆ページ数:156
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:科学機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は止血/凝固アナライザーの世界市場が2020年38億ドルから2025年50億ドルまで、年平均5.7%成長すると見込んでいます。本調査レポートでは、止血/凝固アナライザーの世界市場を詳細に調査・分析し、イントロダクション、調査手法、プレミアムインサイト、市場概要、製品別(臨床検査分析、ポイントオブケアテストアナラ​​イザー)分析、検査別(プロトロンビン時間検査、D-ダイマー検査、フィブリノゲン検査、活性化凝固時間検査、活性化部分トロンボプラスチン時間検査)分析、技術別(光技術、機械技術、電気化学技術、その他)分析、エンドユーザー別(病院、臨床検査室、その他)、地域別分析、競争状況、企業評価・企業概要などを含めています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・止血/凝固アナライザーの世界市場規模:製品別(臨床検査分析、ポイントオブケアテストアナラ​​イザー)
・止血/凝固アナライザーの世界市場規模:検査別(プロトロンビン時間検査、D-ダイマー検査、フィブリノゲン検査、活性化凝固時間検査、活性化部分トロンボプラスチン時間検査)
・止血/凝固アナライザーの世界市場規模:技術別(光技術、機械技術、電気化学技術、その他)
・止血/凝固アナライザーの世界市場規模:エンドユーザー別(病院、臨床検査室、その他)
・止血/凝固アナライザーの世界市場規模:地域別
・競争状況
・企業評価・企業概要

“Coagulation analyzers market to register a CAGR of 5.7% from 2020 to 2025”
The global coagulation analyzers market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases and blood disorders and the rising geriatric population. However, the high cost of fully automated coagulation analyzers is estimated to restrain the growth of this market during the forecast period.

“Optical technology segment is expected to grow at the highest rate during the forecast period”
The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology. However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies. The most widely used technology in the coagulation analyzers market is the optical technology. This segment is expected to account for the largest share of the market in 2020.

“Clinical laboratory analyzers segment is estimated to account for the largest share of the coagulation analyzers market in 2020”
Clinical laboratory analyzers are estimated to account for the largest share of the coagulation analyzers market in 2020. The clinical laboratory analyzers market includes systems and consumables. Systems are further classified as automated, semi-automated, and manual systems, while consumables are classified into reagents and standards, controls, and calibrations. The growing prevalence of blood disorders and increasing development of automated coagulation systems with faster turnaround times, compact size, and expanded capabilities are driving the growth of this market.

“Prothrombin time tests segment is expected to dominate the coagulation analyzers market during the forecast period”
Based on test, the coagulation analyzers market is segmented into prothrombin time (PT/INR) testing, fibrinogen testing, activated partial thromboplastin time testing, D-dimer testing, ACT testing, platelet function tests, anti-factor XA tests, heparin and protamine dose-response tests for ACT, and other coagulation tests. In 2020, the prothrombin time testing segment is estimated to account for the largest share of the coagulation analyzers market. However, the D-dimer tests segment is projected to register the highest CAGR from 2020 to 2025.

“North America is expected to dominate the coagulation analyzers market in 2020”
North America (comprising the US and Canada) is expected to account for the largest share of the global coagulation analyzers market in 2020, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the coagulation analyzers market in North America. However, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
• By Designation: C-level (45%), Director-level (30%), and Others (25%)
• By Region: North America (35%), Europe (30%), Asia Pacific (25%), Latin America (5%), and Middle East & Africa (5%)

The key players operating in this market include Abbott Laboratories (US), Danaher (US), Siemens Healthineers Group (Germany), Sysmex Group (US), Thermo Fisher Scientific (US), Horiba (Japan), Nihon Kohden (Japan), Roche Diagnostics (Switzerland), Maccura Biotechnology Co. Ltd. (China), Bio Group Medical System (Italy), Genrui Biotech Inc. (China), A&T Corporation (Japan), Beijing Succeeder Technology Inc. (China), Diagnostica Stago SAS (France), Helena Laboratories (US), Hycel (Austria), Eurolyser (Austria), Bpc Biosed Srl (Italy), Robimes India Pvt. Ltd (India), Meril Life Sciences (India), ERBA Diagnostics, Inc. (US), Sclavo Diagnostics International S.r.l (Italy), Haematonics (US), Biosystems S.A. (Spain), and ACON (US). Product launches & approvals, expansions, collaborations, agreements, partnerships, and acquisitions are the key growth strategies followed by a majority of players in this market.

Research Coverage
• The report studies the coagulation analyzers market based on test, technology, product, end user, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total coagulation analyzers market
• The report forecasts the revenue of market segments with respect to five major regions

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the coagulation analyzers offered by the key 18 players in the coagulation analyzers market. The report analyzes the coagulation analyzers market by test, technology, product, end user, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various coagulation analyzers, their adoption, and type of tests across key geographic regions.
• Market Diversification: Exhaustive information about new product launches & approvals, untapped geographies, recent developments, and investments in the coagulation analyzers market
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the coagulation analyzers market along with a competitive leadership mapping of up to 25 players in the market.

【レポートの目次】

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 20
1.7 SUMMARY OF CHANGES MADE 20

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH APPROACH 21
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 23
2.1.2.1 Breakdown of primaries 23
2.2 MARKET SIZE ESTIMATION 24
2.2.1 BOTTOM-UP APPROACH 24
2.2.2 TOP-DOWN APPROACH 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 ASSUMPTIONS FOR THE STUDY 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 32
4.1 COAGULATION ANALYZERS MARKET OVERVIEW 32
4.2 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT & COUNTRY (2020) 32
4.3 COAGULATION ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS 34
5.2.1 DRIVERS 35
5.2.1.1 Increasing prevalence of cardiovascular diseases and
blood disorders 35
5.2.1.2 Rising geriatric population 36
5.2.1.3 Technological advancements 37
5.2.2 RESTRAINTS 38
5.2.2.1 High cost of fully automated coagulation analyzers 38
5.2.3 OPPORTUNITIES 38
5.2.3.1 Emerging markets 38
5.2.3.2 Growing reagent rental business 38
5.2.4 CHALLENGES 39
5.2.4.1 Stringent and time-consuming regulatory processes significantly increasing the gestation period for product launches 39

6 COAGULATION ANALYZERS MARKET, BY PRODUCT 40
6.1 INTRODUCTION 41
6.2 CLINICAL LABORATORY ANALYZERS 41
6.2.1 CONSUMABLES 42
6.2.1.1 Reagents 43
6.2.1.1.1 Reagents accounted for the largest share of
the consumables market in 2019 43
6.2.1.2 Standards, Controls, and Calibrations 44
6.2.1.2.1 Standards, controls, and calibrations play an important role in ensuring the performance and accuracy of instruments 44
6.2.2 SYSTEMS 45
6.2.2.1 Automated systems 46
6.2.2.1.1 Fully automated systems deliver results with high accuracy and precision in shorter periods 46
6.2.2.2 Semi-automated systems 47
6.2.2.2.1 Cost-effectiveness of semi-automated systems to drive their adoption 47
6.2.2.3 Manual systems 48
6.2.2.3.1 Manual systems to witness lower growth during
the forecast period 48
6.3 POINT-OF-CARE TESTING ANALYZERS 48
6.3.1 POC TESTING ANALYZERS TO WITNESS HIGH DEMAND GROWTH IN
THE COMING YEARS 48

7 COAGULATION ANALYZERS MARKET, BY TEST 50
7.1 INTRODUCTION 51
7.2 PROTHROMBIN TIME TESTING 52
7.2.1 PT/INR TESTS DOMINATED THE MARKET IN 2019 52
7.3 D-DIMER TESTING 53
7.3.1 D-DIMER TESTS ARE USED TO CHECK BLOOD CLOTTING ISSUES 53
7.4 FIBRINOGEN TESTING 54
7.4.1 GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO INCREASE
THE DEMAND FOR FIBRINOGEN TESTS 54
7.5 ACTIVATED CLOTTING TIME TESTING 56
7.5.1 ACT TESTS HELP HEALTHCARE PROVIDERS TO FIND THE RIGHT DOSAGE
OF HEPARIN 56
7.6 ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTING 56
7.6.1 GROWING NUMBER OF ANGIOPLASTY AND DIALYSIS PROCEDURES TO SUPPORT MARKET GROWTH 56
7.7 PLATELET FUNCTION TESTS 58
7.7.1 PLATELET FUNCTION TESTS ARE PERFORMED TO EVALUATE THE ABILITY OF PLATELETS TO CLUMP TOGETHER 58
7.8 ANTI-FACTOR XA TESTS 59
7.8.1 ANTI-FACTOR XA TESTS AID IN THE MONITORING OF STANDARD HEPARIN THERAPY FOR UFH 59
7.9 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT 60
7.9.1 DUE TO LIMITED APPLICATIONS, THIS TEST SEGMENT HAS A VERY SMALL SHARE IN THE COAGULATION ANALYZERS MARKET 60
7.10 OTHER COAGULATION TESTS 61

8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY 62
8.1 INTRODUCTION 63
8.2 OPTICAL TECHNOLOGY 63
8.2.1 OPTICAL TECHNOLOGY SEGMENT DOMINATED THE MARKET IN 2019 63
8.3 MECHANICAL TECHNOLOGY 64
8.3.1 MECHANICAL ANALYZERS ARE NOT AFFECTED BY ICTERIC OR
LIPEMIC PLASMA 64
8.4 ELECTROCHEMICAL TECHNOLOGY 65
8.4.1 INCREASING DEMAND FOR SELF-TESTING TO DRIVE MARKET GROWTH 65
8.5 OTHER TECHNOLOGIES 65

9 COAGULATION ANALYZERS MARKET, BY END USER 67
9.1 INTRODUCTION 68
9.2 HOSPITALS 68
9.2.1 HIGH PREVALENCE OF BLOOD-RELATED DISORDERS WILL RESULT IN HIGH MARKET GROWTH 68
9.3 CLINICAL LABORATORIES 69
9.3.1 CLINICAL LABORATORIES FORMED THE LARGEST END-USER SEGMENT IN THIS MARKET 69
9.4 OTHER END USERS 70

10 COAGULATION ANALYZERS MARKET, BY REGION 71
10.1 INTRODUCTION 72
10.2 NORTH AMERICA 73
10.2.1 US 76
10.2.1.1 Favorable research scenario will drive market growth in the US 76
10.2.2 CANADA 78
10.2.2.1 Rising demand for blood and blood components to support
market growth 78
10.3 EUROPE 80
10.3.1 GERMANY 83
10.3.1.1 Increasing incidence of HIV is a major factor driving the growth of
the coagulation analyzers market in Germany 83
10.3.2 UK 85
10.3.2.1 Government support to develop innovative diagnostic kits will boost market growth in the UK 85
10.3.3 FRANCE 87
10.3.3.1 Presence of proper protocols and guidelines for diagnostics to propel market growth in France 87
10.3.4 ITALY 89
10.3.4.1 Increasing preference for coagulation testing during transplantation will result in market growth 89
10.3.5 SPAIN 91
10.3.5.1 Consolidation of laboratories in Spain will drive market growth 91
10.3.6 REST OF EUROPE 93
10.4 ASIA PACIFIC 95
10.4.1 CHINA 97
10.4.1.1 Government initiatives and improving healthcare infrastructure to aid market growth 97
10.4.2 JAPAN 99
10.4.2.1 Rising POC testing will contribute to market growth in Japan 99
10.4.3 INDIA 100
10.4.3.1 High burden of chronic diseases to support market growth 100
10.4.4 REST OF ASIA PACIFIC 102
10.5 LATIN AMERICA 104
10.5.1 DEARTH OF QUALIFIED HEALTHCARE PROFESSIONALS TO RESTRAIN MARKET GROWTH IN LATAM 104
10.6 MIDDLE EAST & AFRICA 106
10.6.1 HIGH PREVALENCE OF BLOOD DISORDERS TO SUPPORT MARKET GROWTH IN THE MEA 106

11 COMPETITIVE LANDSCAPE 109
11.1 OVERVIEW 109
11.2 MARKET RANKING ANALYSIS 110
11.3 COMPETITIVE LEADERSHIP MAPPING 111
11.3.1 VISIONARY LEADERS 111
11.3.2 INNOVATORS 111
11.3.3 DYNAMIC DIFFERENTIATORS 111
11.3.4 EMERGING COMPANIES 111
11.4 COMPETITIVE SITUATION AND TRENDS 113
11.4.1 PRODUCT LAUNCHES AND ENHANCEMENTS 113
11.4.2 PARTNERSHIPS AND AGREEMENTS 113
11.4.3 MERGERS & ACQUISITIONS 114

12 COMPANY PROFILES 115
(Business overview, Products offered, Recent developments, COVID-19 Impact, MNM view)*
12.1 ABBOTT LABORATORIES 115
12.2 THERMO FISHER SCIENTIFIC, INC. 117
12.3 NIHON KOHDEN CORPORATION 119
12.4 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) 121
12.5 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG) 123
12.6 SYSMEX CORPORATION 127
12.7 DANAHER CORPORATION 131
12.8 HORIBA 133
12.9 DIAGNOSTICA STAGO SAS 136
12.10 HELENA LABORATORIES CORPORATION 138
12.11 MACCURA BIOTECHNOLOGY CO., LTD. 140
12.12 BEIJING SUCCEEDER TECHNOLOGY INC. 141
12.13 HYCEL HANDELSGES.M.B.H. 142
12.14 GENRUI BIOTECH INC. 143
12.15 ERBA DIAGNOSTICS MANNHEIM GMBH (A TRANSASIA BIO-MEDICALS LTD. COMPANY) 144
12.16 BIO-GROUP MEDICAL SYSTEM 145
12.17 ROBIMES INDIA PVT. LTD. 146
12.18 MERIL LIFE SCIENCES PVT. LTD. 147
*Business overview, Products offered, Recent developments, COVID-19 Impact, MNM view might not be captured in case of unlisted companies.

13 APPENDIX 148
13.1 DISCUSSION GUIDE 148
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 152
13.3 AVAILABLE CUSTOMIZATIONS 154
13.4 RELATED REPORTS 154
13.5 AUTHOR DETAILS 155

LIST OF TABLES

TABLE 1 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 AND 2050 37
TABLE 2 COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 41
TABLE 3 CLINICAL LABORATORY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 42
TABLE 4 CLINICAL LABORATORY ANALYZERS MARKET, BY REGION,
2018–2025 (USD MILLION) 42
TABLE 5 CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 42
TABLE 6 CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET,
BY REGION, 2018–2025 (USD MILLION) 43
TABLE 7 REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 44
TABLE 8 STANDARDS, CONTROLS, AND CALIBRATIONS MARKET, BY REGION,
2018–2025 (USD MILLION) 44
TABLE 9 CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 45
TABLE 10 CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET,
BY REGION, 2018–2025 (USD MILLION) 45
TABLE 11 AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 46
TABLE 12 SEMI-AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 47
TABLE 13 MANUAL SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 48
TABLE 14 POC TESTING ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION) 49
TABLE 15 COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 51
TABLE 16 PROTHROMBIN TIME TESTING MARKET, BY REGION, 2018–2025 (USD MILLION) 53
TABLE 17 D-DIMER TESTING MARKET, BY REGION, 2018–2025 (USD MILLION) 54
TABLE 18 FIBRINOGEN TESTING MARKET, BY REGION, 2018–2025 (USD MILLION) 55
TABLE 19 ACT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION) 56
TABLE 20 APTT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION) 57
TABLE 21 PLATELET FUNCTION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION) 59
TABLE 22 ANTI-FACTOR XA TESTS MARKET, BY REGION, 2018–2025 (USD MILLION) 60
TABLE 23 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT MARKET, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 24 OTHER COAGULATION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 25 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 63
TABLE 26 OPTICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 64
TABLE 27 MECHANICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 64
TABLE 28 ELECTROCHEMICAL TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 65
TABLE 29 OTHER TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION) 66
TABLE 30 COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION) 68
TABLE 31 HOSPITALS MARKET, BY REGION, 2018–2025 (USD MILLION) 69
TABLE 32 CLINICAL LABORATORIES MARKET, BY REGION, 2018–2025 (USD MILLION) 70
TABLE 33 OTHER END USERS MARKET, BY REGION, 2018–2025 (USD MILLION) 70
TABLE 34 COAGULATION ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION) 72
TABLE 35 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 74
TABLE 36 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 74
TABLE 37 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 74
TABLE 38 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION) 75
TABLE 39 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 75
TABLE 40 US: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 76
TABLE 41 US: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 77
TABLE 42 US: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 77
TABLE 43 US: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 78
TABLE 44 CANADA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 78
TABLE 45 CANADA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 79
TABLE 46 CANADA: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION) 79
TABLE 47 CANADA: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 80
TABLE 48 EUROPE: COAGULATION ANALYZERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 80
TABLE 49 EUROPE: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 81
TABLE 50 EUROPE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 81
TABLE 51 EUROPE: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION) 82
TABLE 52 EUROPE: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 82
TABLE 53 GERMANY: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 83
TABLE 54 GERMANY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 83
TABLE 55 GERMANY: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION) 84
TABLE 56 GERMANY: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 84
TABLE 57 UK: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 85
TABLE 58 UK: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 86
TABLE 59 UK: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 86
TABLE 60 UK: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 87
TABLE 61 FRANCE: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 87
TABLE 62 FRANCE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 88
TABLE 63 FRANCE: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION) 88
TABLE 64 FRANCE: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 89
TABLE 65 ITALY: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 89
TABLE 66 ITALY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 90
TABLE 67 ITALY: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 90
TABLE 68 ITALY: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 91
TABLE 69 SPAIN: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 91
TABLE 70 SPAIN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 92
TABLE 71 SPAIN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 92
TABLE 72 SPAIN: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 93
TABLE 73 ROE: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 93
TABLE 74 ROE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 94
TABLE 75 ROE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 94
TABLE 76 ROE: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 95
TABLE 77 APAC: COAGULATION ANALYZERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 95
TABLE 78 APAC: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 95
TABLE 79 APAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 96
TABLE 80 ASIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 96
TABLE 81 APAC: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 97
TABLE 82 CHINA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 97
TABLE 83 CHINA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 98
TABLE 84 CHINA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 98
TABLE 85 CHINA: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 99
TABLE 86 JAPAN: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 99
TABLE 87 JAPAN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 99
TABLE 88 JAPAN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 100
TABLE 89 JAPAN: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 100
TABLE 90 INDIA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 101
TABLE 91 INDIA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 101
TABLE 92 INDIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 102
TABLE 93 INDIA: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 102
TABLE 94 ROAPAC: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 103
TABLE 95 ROAPAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 103
TABLE 96 ROAPAC: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION) 103
TABLE 97 ROAPAC: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 104
TABLE 98 LATAM: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 104
TABLE 99 LATAM: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 105
TABLE 100 LATAM: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION) 105
TABLE 101 LATAM: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 106
TABLE 102 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 106
TABLE 103 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 107
TABLE 104 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION) 107
TABLE 105 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION) 108


LIST OF FIGURES

FIGURE 1 COAGULATION ANALYZERS MARKET SEGMENTATION 18
FIGURE 2 RESEARCH DESIGN 21
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 23
FIGURE 4 COAGULATION ANALYZERS MARKET: TOP-DOWN APPROACH 25
FIGURE 5 DATA TRIANGULATION METHODOLOGY 26
FIGURE 6 COAGULATION ANALYZERS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 28
FIGURE 7 COAGULATION ANALYZERS MARKET, BY TEST, 2020 VS. 2025 (USD MILLION) 29
FIGURE 8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 30
FIGURE 9 COAGULATION ANALYZERS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 30
FIGURE 10 COAGULATION ANALYZERS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION) 31
FIGURE 11 INCREASING PREVALENCE OF BLOOD DISORDERS TO DRIVE MARKET GROWTH 32
FIGURE 12 CLINICAL LABORATORY ANALYZERS SEGMENT IS EXPECTED TO ACCOUNT FOR
THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020 32
FIGURE 13 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD 33
FIGURE 14 COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 34
FIGURE 15 NORTH AMERICA: COAGULATION ANALYZERS MARKET SNAPSHOT 73
FIGURE 16 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM JANUARY 2017 TO MARCH 2020 109
FIGURE 17 COAGULATION ANALYZERS MARKET RANKING ANALYSIS, BY PLAYER, 2019 110
FIGURE 18 COAGULATION ANALYZERS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 112
FIGURE 19 ABBOTT LABORATORIES: COMPANY SNAPSHOT 115
FIGURE 20 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 117
FIGURE 21 NIHON KOHDEN: COMPANY SNAPSHOT (2019) 119
FIGURE 22 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019) 121
FIGURE 23 SIEMENS HEALTHINEERS GROUP: COMPANY SNAPSHOT (2019) 124
FIGURE 24 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019) 127


★調査レポート[止血/凝固アナライザーの世界市場予測(~2025):製品別、検査別、技術別、エンドユーザー別] ( Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals) - Global Forecast to 2025 / AST 7689) 販売に関する免責事項
[止血/凝固アナライザーの世界市場予測(~2025):製品別、検査別、技術別、エンドユーザー別] ( Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals) - Global Forecast to 2025 / AST 7689) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆